Suven Pharmaceuticals, an integrated global CDMO (Contract Development and Manufacturing Organization), has rebranded as Cohance Lifesciences.
Hyderabad-based CDMO company, Cohance Lifesciences offers services to leading global pharmaceutical and fine chemical majors in their NCE development endeavours.
“The transition to Cohance Lifesciences marks a pivotal moment in our commitment to better serve our customers and their end market. We are building a global CDMO that aims to enable innovation across a broad range of modalities, chemistries, and technologies, to advance solutions for a healthier world,” said Cohance Executive Chairman, Vivek Sharma.
